Halting ErbB-2 Isoforms Retrograde Transport to the Nucleus as a New Theragnostic Approach for Triple-Negative Breast Cancer

Investigators demonstrated that ErbB-2 was localized in the nucleus, NErbB-2, of TNBC cells and primary tumors, from where it drives growth.